e.l.f. Cosmetics Acquires Hailey Bieber's Rhode Beauty Brand for $1 Billion
e.l.f. Beauty has acquired Hailey Bieber's rhode skincare brand in a $1 billion deal, the companies said.
Bieber's rhode had $212 million in net sales in the 12 months that ended March 31. The company's products are only available online, but by the end of this year it plans to begin an in-store partnership with Sephora in North America and the UK.
Bieber, a model and the wife of singer Justin Bieber, will be rhode's chief creative officer and head of innovation and also a strategic advisor to the combined companies.
Under the terms of the agreement, e.l.f. will acquire rhode for $600 million in cash and $200 million of newly issued shares of e.l.f. Beauty common stock. The deal also includes an additional potential earnout of $200 million based on the future growth of the brand over three years.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Arab News
5 hours ago
- Arab News
Review: ‘Doom: The Dark Ages' sets new bar for first-person carnage
LONDON: The first 'Doom' game back in 1993 helped define the first-person shooter genre, spawning numerous sequels and even a Hollywood film. Now it is back, and in a crowded market packed with chaotic shooters and arena brawlers, this game slices its way into the pantheon with style — and a spinning shield saw. For the latest updates, follow us on Instagram @ Boasting 22 adrenaline-soaked levels, 'Doom: The Dark Ages' sticks to the classic formula of annihilating every enemy in the room before moving on. Yet it rarely pauses for breath, charging through its campaign. While there are secrets to uncover and collectible toys to find, it always feels hurried, pushing players forward with breakneck urgency. Where it stands out is in its innovative combat tools — a shield saw that doubles as a melee weapon, a flail for crowd control, and a shield charge that turns defense into offense. Combat is fast, demanding, and utterly satisfying, especially in boss fights where success hinges on timing and picking the right attack for the enemy. The gunplay is awesomely brutal and weapons evolve through Sentinel Shrines, letting players fine-tune their arsenal to match the rising difficulty. This isn't just a shooter; it's a metal-fueled ballet of aggression, where being passive is punished and staying alive means staying angry. The music? Pure heavy metal fury, matching the gameplay beat for beat. Visuals run at a crisp 60 frames per second and every environment drips with cosmic dread, from crumbling hellscapes to star-forged citadels. The new cosmic realm adds visual diversity, while massive set-pieces like dragon-riding with autocannons and piloting giant sentinels crank the spectacle to 11. This is bone-crunching mayhem at its finest. It's Halo-esque in scope, 'Doom'-like in execution, but ultimately a beast of its own making.
Asharq Al-Awsat
6 hours ago
- Asharq Al-Awsat
UK Ban on Disposable Vapes Goes into Effect
A ban on disposable vapes goes into effect across the UK on Sunday in a bid to protect children's health and tackle a "throwaway" culture. "For too long, single-use vapes have blighted our streets as litter and hooked our children on nicotine," junior environment minister Mary Creagh said. She said the government was calling "time on these nasty devices" -- a type of e-cigarette which are very popular with young people -- and banning sales of single-use vapes or their supply in a crackdown on UK corner shops and supermarkets. Those caught flouting the ban will face a £200 fine ($269), while repeat offenders risk up to two years in prison, AFP reported. Young people and children in particular have been attracted to cheap and colorful disposable vapes, which have snazzy flavors such as mint, chocolate, mango or watermelon, since they were introduced in the UK in 2021. In 2024, nearly five million disposable vapes were thrown away each week, according to Material Focus, an independent UK-based non-profit. More than 40 tons of lithium, a key metal used in the technology industry, was discarded each year along with single-use vapes -- enough to power 5,000 electrical vehicles, the NGO said. Fire services have also warned about the risk of discarded vapes catching light among household rubbish. "Every vape has potential to start a fire if incorrectly disposed of," said Justin Greenaway, commercial manager at electronic waste processing company SWEEEP Kuusakoski. The new law, first proposed by the previous Conservative government, also aims to stem a rise in vaping. "This new law is a step towards reducing vaping among children, while ensuring products are available to support people to quit smoking," said Caroline Cerny, deputy chief executive for health charity Action on Smoking and Health (ASH). A recent ASH survey said 11 percent of adults vape, or about 5.6 million people, and 18 percent of 11 to 17 year olds -- about 980,000 under-18s. Among vapers, some 52 percent of young adults aged between 18 to 24 preferred single-use vapes. The long-term health risks of vaping remain unclear. E-cigarettes do not produce tar or carbon monoxide, two of the most harmful elements in tobacco smoke. But they do still contain highly addictive nicotine. The upcoming ban has already led to a fall in disposable vapes. According to ASH, the use of disposables by 18-24-year-old vapers fell from 52 percent in 2024 to 40 percent in 2025. The UK ban follows similar European moves. Belgium and France became the first EU countries to ban sales of disposable vapes. Ireland is also preparing to introduce new restrictions. But critics have argued many users will simply switch to refillable or reusable vaping devices, which will limit the impact on nicotine consumption. And industry experts say the ban could lead to more illegal products entering the UK market. The bill "only makes it illegal to sell disposable vapes -- it does not prohibit their use," warned Dan Marchant, director of Vape Club, the UK's largest online vape retailer. "We risk a surge of illegal and potentially dangerous items flooding the black market."
Al Arabiya
8 hours ago
- Al Arabiya
US FDA approves Moderna's next-generation COVID vaccine for adults
The US Food and Drug Administration has approved Moderna's next-generation COVID-19 vaccine for everyone aged 65 and above, the company said on Saturday, the first endorsement since the regulator tightened requirements. The vaccine has also been approved for people aged 12 to 64 with at least one or more underlying risk factors defined by the Centers for Disease Control and Prevention, Moderna said in a statement. The company said it expects to have the vaccine, called mNEXSPIKE, available for the 2025-2026 respiratory virus season. 'The FDA approval of our third product, mNEXSPIKE, adds an important new tool to help protect people at high risk of severe disease from COVID-19,' CEO Stephane Bancel said in the statement. The Department of Health and Human Services, under the leadership of long-time vaccine skeptic Robert F. Kennedy Jr., is tightening regulatory scrutiny on vaccines. The FDA said on May 20 it planned to require drugmakers to test their COVID booster shots against an inert placebo in healthy adults under 65 for approval, effectively limiting them to older adults and those at risk of developing severe illness. The Moderna vaccine can be stored in refrigerators rather than freezers, to offer longer shelf life and make distribution easier, especially in developing countries where supply-chain issues could hamper vaccination drives. The Centers for Disease Control and Prevention, which Kennedy also oversees, said on Thursday that COVID vaccines remain an option for healthy children when parents and doctors agree that it is needed, stopping short of Kennedy's announcement days earlier that the agency would remove the shots from its immunization schedule. The CDC announcement eases investor concern to some extent, analysts say, as it keeps the existing framework for older adults and at-risk people who generally seek out the shots. FDA leaders have said 100 million to 200 million Americans would still be eligible for annual shots. Moderna is betting on its newer messenger RNA vaccines as it grapples with waning demand for its original COVID vaccine Spikevax and lower-than-expected uptake of its respiratory syncytial virus vaccine. The approval for mNEXSPIKE was based on late-stage trial data, which showed the shot was not inferior in efficacy compared to Spikevax in individuals aged 12 years and older. The shot also showed superior efficacy compared to Spikevax in adults 18 years of age and older in the study. Kennedy has kickstarted a major overhaul of health departments, laying off thousands of employees to align with President Donald Trump's goal of dramatically shrinking the federal government. This has further ignited worries about potential disruptions to the regulatory review of treatments and vaccines. The CDC's outside panel of vaccine experts in April discussed recommending the booster shots only for populations at risk of severe COVID-19 for the upcoming immunization campaign. The FDA approved Novavax's COVID vaccine Nuvaxovid this month, limiting its use to older adults and people over the age of 12 with conditions that put them at risk due to the illness. Conditions that constitute additional risk range from illnesses such as diabetes and heart disease to behaviors like physical inactivity and substance abuse, according to the CDC. While Moderna's shots, as well as Pfizer-BioNTech's Comirnaty, are mRNA-based, Novavax's vaccine is protein-based and takes longer to manufacture. Moderna this month withdrew an application seeking approval for its flu-and-COVID combination vaccine candidate to wait for efficacy data from a late-stage trial of its influenza shot.
